Neuroprotection. Cholinergic therapy. Neurogenesis. Gliatilin: 25 years in Russia
Main Author: | Editorial Article |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2018-07-01
|
Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
Online Access: | https://www.bekhterevreview.com/jour/article/view/121 |
Similar Items
-
Choline Alphoscerat (Gliatilin) in the pathogenetic therapy of Alzheimer’s disease
by: D. V. Zaharov, et al.
Published: (2019-02-01) -
Gliatilin in the treatment of patients in the recovery period of cerebral stroke
by: V. N. Mishchenko, et al.
Published: (2018-07-01) -
New aspects of gliatilin’ application for treating of patients with mild cognitive impairment
by: S. M. Moroz, et al.
Published: (2018-07-01) -
Multicentral pilot clinical trial of gliatilin in treatment of acute ischemic stroke
by: M. M. Odinak, et al.
Published: (2017-02-01) -
Microglia and Macrophages in Neuroprotection, Neurogenesis, and Emerging Therapies for Stroke
by: Susanna R. Var, et al.
Published: (2021-12-01)